...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.
【24h】

Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.

机译:芳基罗丹宁能特异性抑制葡萄球菌和肠球菌生物膜的形成。

获取原文
获取原文并翻译 | 示例
           

摘要

Staphylococcus epidermidis and Staphylococcus aureus are the leading causative agents of indwelling medical device infections because of their ability to form biofilms on artificial surfaces. Here we describe the antibiofilm activity of a class of small molecules, the aryl rhodanines, which specifically inhibit biofilm formation of S. aureus, S. epidermidis, Enterococcus faecalis, E. faecium, and E. gallinarum but not the gram-negative species Pseudomonas aeruginosa or Escherichia coli. The aryl rhodanines do not exhibit antibacterial activity against any of the bacterial strains tested and are not cytotoxic against HeLa cells. Preliminary mechanism-of-action studies revealed that the aryl rhodanines specifically inhibit the early stages of biofilm development by preventing attachment of the bacteria to surfaces.
机译:表皮葡萄球菌和金黄色葡萄球菌是留置医疗器械感染的主要病原体,因为它们能够在人造表面上形成生物膜。在这里,我们描述了一类小分子芳基罗丹宁的抗生物膜活性,该小分子特异性抑制金黄色葡萄球菌,表皮葡萄球菌,粪肠球菌,粪肠球菌和鸡肠球菌的生物膜形成,但不包括革兰氏阴性菌假单胞菌铜绿菌或大肠杆菌。芳基罗丹宁对任何测试的细菌菌株均未表现出抗菌活性,并且对HeLa细胞无细胞毒性。初步的作用机理研究表明,芳基罗丹丹酮可通过防止细菌附着在表面上而特异性抑制生物膜发育的早期阶段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号